Ospolot (Sultiame)

Sultiame, the active ingredient in Ospolot, is a carbonic anhydrase inhibitor presented as a tablet for oral use. It is employed in the management of certain kidney-related conditions, particularly in patients requiring dialysis.\n\nGNH India supplies Ospolot as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Ospolot is used primarily by the pharmac of the renal pathway to address the following conditions:\n\n- Chronic Kidney Disease: Helps to reduce the progression of the disease by modifying acid‑base balance and electrolyte levels\n- Dialysis Patients of the   \n-  \n- \n- \n- \n

Sultiac  

...